Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Kymera Therapeutics Inc (NASDAQ: KYMR) was $33.56 for the day, up 9.32% from the previous closing price of $30.70. In other words, the price has increased by $9.32 from its previous closing price. On the day, 1.3 million shares were traded. KYMR stock price reached its highest trading level at $33.8 during the session, while it also had its lowest trading level at $30.75.
Ratios:
Our analysis of KYMR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.53 and its Current Ratio is at 7.53. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $52.
On December 10, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $60.
On December 06, 2024, BMO Capital Markets started tracking the stock assigning a Market Perform rating and target price of $55.BMO Capital Markets initiated its Market Perform rating on December 06, 2024, with a $55 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 03 ’25 when Chiniara Ellen sold 2,241 shares for $30.45 per share. The transaction valued at 68,239 led to the insider holds 80,085 shares of the business.
Chadwick Jeremy G sold 1,383 shares of KYMR for $42,113 on Mar 03 ’25. The Chief Operating Officer now owns 67,800 shares after completing the transaction at $30.45 per share. On Mar 03 ’25, another insider, Jacobs Bruce N., who serves as the Chief Financial Officer of the company, sold 7,035 shares for $30.45 each. As a result, the insider received 214,219 and left with 201,886 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYMR now has a Market Capitalization of 2179524096 and an Enterprise Value of 1778542208. For the stock, the TTM Price-to-Sale (P/S) ratio is 46.30 while its Price-to-Book (P/B) ratio in mrq is 2.61. Its current Enterprise Value per Revenue stands at 37.783 whereas that against EBITDA is -7.093.
Stock Price History:
The Beta on a monthly basis for KYMR is 2.14, which has changed by 0.0056937933 over the last 52 weeks, in comparison to a change of 0.07545352 over the same period for the S&P500. Over the past 52 weeks, KYMR has reached a high of $53.27, while it has fallen to a 52-week low of $19.44. The 50-Day Moving Average of the stock is 9.24%, while the 200-Day Moving Average is calculated to be -17.98%.
Shares Statistics:
KYMR traded an average of 697.50K shares per day over the past three months and 852880 shares per day over the past ten days. A total of 64.89M shares are outstanding, with a floating share count of 53.88M. Insiders hold about 17.03% of the company’s shares, while institutions hold 95.06% stake in the company. Shares short for KYMR as of 1743379200 were 7990149 with a Short Ratio of 11.46, compared to 1740700800 on 7575085. Therefore, it implies a Short% of Shares Outstanding of 7990149 and a Short% of Float of 13.73.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
